67 results
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
:
Analyst Price Target Analysis. Centerview reviewed available stock price targets for the Company Shares in thirteen publicly available Wall Street … research analyst reports, which indicated low and high stock price targets for Cerevel ranging from $24.00 to $42.00 per Company Share, with the median
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
of approximately $20.26 to $35.59 per Company Share;
Analyst Price Target Analysis. Centerview reviewed stock price targets for the Company Shares in publicly … available Wall Street research analyst reports, which indicated low and high stock price targets for Cerevel ranging from $24.00 to $42.00 per
PRER14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Preliminary revised proxy
7:19am
for Cerevel during such period of approximately $20.26 to $35.59 per Company Share;
Analyst Price Target Analysis. Centerview reviewed stock price targets … for the Company Shares in publicly available Wall Street research analyst reports, which indicated low and high stock price targets for Cerevel ranging
PREM14A
w586v8
5 Jan 24
Preliminary proxy related to merger
5:13pm
424B5
riu19k
12 Oct 23
Prospectus supplement for primary offering
4:16pm
424B5
dvuid6cc
11 Oct 23
Prospectus supplement for primary offering
4:08pm
424B5
na9li
12 Aug 22
Prospectus supplement for primary offering
4:58pm
424B5
nois8nigp
10 Aug 22
Prospectus supplement for primary offering
4:15pm
424B3
kxen9juzt2ya
10 Nov 21
Prospectus supplement
6:53am